Role of gastroenterologists and healthcare providers in promoting COVID-19 immunization among individuals with inflammatory bowel disease: A systematic review and meta-analysis on a global scale

References

• CDC. Inflammatory bowel disease (IBD). 2023 Apr 17 [accessed 2023 july 24]. https://www.cdc.gov/ibd/features//IBD-more-chronic-diseases.html.
   Google Scholar
• Chang JT, Longo DL. Pathophysiology of inflammatory bowel diseases. N Engl J Med. 2020 Dec 31;383(27):2652–11. doi:10.1056/NEJMra2002697.
   PubMed Web of Science ®Google Scholar
• Saez A, Herrero-Fernandez B, Gomez-Bris R, Sánchez-Martinez H, Gonzalez-Granado JM. Pathophysiology of inflammatory bowel disease: innate immune system. Int J Mol Sci. 2023 Jan 12;24(2):1526. doi:10.3390/ijms24021526.
   PubMed Web of Science ®Google Scholar
• Kubas A, Malecka-Wojciesko E. COVID-19 vaccination in Inflammatory Bowel disease (IBD). J Clin Med. 2022 May 9;11(9):2676. doi:10.3390/jcm11092676.
   PubMed Web of Science ®Google Scholar
• CDC. Inflammatory bowel disease (IBD). Comorbidities. 2022 Apr 14 [accessed 2023 july 24]. https://www.cdc.gov//ibd/features/IBD-more-chronic-diseases.html.
   Google Scholar
• Rahier JF, Magro F, Abreu C, Armuzzi A, Ben-Horin S, Chowers Y, Cottone M, de Ridder L, Doherty G, Ehehalt R, et al. European Crohn’s and Colitis Organisation (ECCO). Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2014 Jun;8(6):443–68. doi:10.1016/j.crohns.2013.12.013.
   PubMed Web of Science ®Google Scholar
• Monteleone G, Ardizzone S. Are patients with inflammatory bowel disease at increased risk for covid-19 infection? J Crohns Colitis. 2020 Sep 16;14(9):1334–6. doi:10.1093/ecco-jcc/jjaa061.
   PubMed Web of Science ®Google Scholar
• Brenner EJ, Ungaro RC, Gearry RB, Kaplan GG, Kissous-Hunt M, Lewis JD, Ng SC, Rahier JF, Reinisch W, Ruemmele FM, et al. Are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry. Gastroenterology. 2020 Aug;159(2):481–91.e3. doi:10.1053/j.gastro.2020.05.032.
   PubMed Web of Science ®Google Scholar
• Xu F, Carlson SA, Wheaton AG, Greenlund KJ. COVID-19 hospitalizations among US medicare beneficiaries with inflammatory bowel disease, April 1 to July 31, 2020. Inflamm Bowel Dis. 2021 Jun 15;27(7):1166–9. doi:10.1093/ibd/izab041.
   PubMed Web of Science ®Google Scholar
• Bezzio C, Saibeni S, Variola A, Allocca M, Massari A, Gerardi V, Casini V, Ricci C, Zingone F, Amato A, et al. Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study. Gut. 2020 Jul;69(7):1213–17. doi:10.1136/gutjnl-2020-321411.
   PubMed Web of Science ®Google Scholar
• Shehab M, Alrashed F, Alfadhli A, Alotaibi K, Alsahli A, Mohammad H, Cherian P, Al-Khairi I, Alphonse Thanaraj T, Channanath A, et al. Serological response to BNT162b2 and ChAdOx1 nCoV-19 vaccines in patients with inflammatory bowel disease on biologic therapies. Vaccines. 2021 Dec 13;9(12):1471. doi:10.3390/vaccines9121471.
   Web of Science ®Google Scholar
• Tabesh E, Soheilipour M, Rezaeisadrabadi M, Zare-Farashbandi E, Mousavi-Roknabadi RS. Comparison the effects and side effects of covid-19 vaccination in patients with inflammatory bowel disease (IBD): a systematic scoping review. BMC Gastroenterol. 2022 Aug 20;22(1):393. doi:10.1186/s12876-022-02460-1.
   PubMed Web of Science ®Google Scholar
• Alexander JL, Liu Z, Muñoz Sandoval D, Reynolds C, Ibraheim H, Anandabaskaran S, Saifuddin A, Castro Seoane R, Anand N, Nice R, et al. VIP study investigators. COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study. Lancet Gastroenterol Hepatol. 2022 Nov;7(11):1005–15. doi:10.1016/S2468-1253(22)00274-6.
   PubMed Web of Science ®Google Scholar
• Weaver KN, Zhang X, Dai X, Watkins R, Adler J, Dubinsky MC, Kastl A, Bousvaros A, Strople JA, Cross RK, et al. Impact of SARS-CoV-2 vaccination on inflammatory bowel disease activity and development of vaccine-related adverse events: results from PREVENT-COVID. Inflamm Bowel Dis. 2022 Oct 3;28(10):1497–505. doi:10.1093/ibd/izab302.
   PubMed Web of Science ®Google Scholar
• James D, Jena A, Bharath PN, Choudhury A, Singh AK, Sebastian S, Sharma V. Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: a systematic review and meta-analysis. Dig Liver Dis. 2022 Jun;54(6):713–21. doi:10.1016/j.dld.2022.03.005.
   PubMedGoogle Scholar
• Alexander JL, Moran GW, Gaya DR, Raine T, Hart A, Kennedy NA, Lindsay JO, MacDonald J, Segal JP, Sebastian S, et al. SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology inflammatory bowel disease section and IBD Clinical Research Group position statement. Lancet Gastroenterol Hepatol. 2021 Mar;6(3):218–24. doi:10.1016/S2468-1253(21)00024-8.
   PubMed Web of Science ®Google Scholar
• Murthy SK, Kuenzig ME, Windsor JW, Ghia JE, Griffiths AM, Panaccione R, Seow CH, Benchimol EI, Bernstein CN, Bitton A, et al. Crohn’s and colitis Canada’s 2021 impact of COVID-19 and inflammatory bowel disease in Canada: COVID-19 vaccines-biology, Current evidence and recommendations. J Can Assoc Gastroenterol. 2021 Nov 5;4(Suppl 2):54–60. doi:10.1093/jcag/gwab033.
   Google Scholar
• CDC. COVID-19 vaccines for people who are moderately or severely immunocompromised. 2024 Mar 8 [accessed 2023 july 21]. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immuno.html.
   Google Scholar
• Kwon HJ, Panagos K, Alizadeh M, Bell M, Bourmaf M, Zisman E, Paul P, Sibel L, Wong U. Patients with inflammatory bowel disease are more hesitant about coronavirus disease 2019 vaccination. Front Med. 2022 Nov 15;9:1005121. doi:10.3389/fmed.2022.1005121.
   Web of Science ®Google Scholar
• Shehab M, Zurba Y, Al Abdulsalam A, Alfadhli A, Elouali S. COVID-19 vaccine hesitancy among patients with inflammatory bowel disease receiving biologic therapies in Kuwait: a cross-sectional study. Vaccines. 2021 Dec 31;10(1):55. doi:10.3390/vaccines10010055.
   Web of Science ®Google Scholar
• Larson HJ. Defining and measuring vaccine hesitancy. Nat Hum Behav. 2022 Dec;6(12):1609–10. doi:10.1038/s41562-022-01484-7.
   PubMed Web of Science ®Google Scholar
• Casanova MJ, Chaparro M, Gisbert JP. Errors in the care of inflammatory bowel disease patients: “errata” study. Gastroenterol Hepatol. 2020 May;43(5):233–9. English, Spanish. doi:10.1016/j.gastrohep.2019.11.001.
   PubMed Web of Science ®Google Scholar
• Ryu HH, Chang K, Kim N, Lee HS, Hwang SW, Park SH, Yang DH, Byeon JS, Myung SJ, Yang SK, et al. Insufficient vaccination and inadequate immunization rates among Korean patients with inflammatory bowel diseases. Medicine (Baltimore). 2021 Nov 12;100(45):e27714. doi:10.1097/MD.0000000000027714.
   PubMed Web of Science ®Google Scholar
• Ford T, Danchin M, McMinn A, Perrett K, Alex G, Crawford NW. Immunisation status of children and adolescents with a new diagnosis of inflammatory bowel disease. BMC Infect Dis. 2022 Jan 4;22(1):6. doi:10.1186/s12879-021-06976-x.
   PubMed Web of Science ®Google Scholar
• Macaluso FS, Mazzola G, Ventimiglia M, Alvisi P, Renna S, Adamoli L, Galli M, Armuzzi A, Ardizzone S, Cascio A, et al. Physicians’ knowledge and application of immunization strategies in patients with inflammatory bowel disease: a survey of the Italian group for the study of inflammatory bowel disease. Digestion. 2020;101(4):433–40. doi:10.1159/000500798.
   PubMed Web of Science ®Google Scholar
• Hammami MB, Pandit P, Salamo RT, Odufalu FD. Schroeder KHealth maintenance and vaccination of patients with inflammatory bowel disease: practice and perception of responsibility of gastroenterologists vs primary care providersOchsner J2019 Fall193210–910.31486/toj.18.0086.
   PubMed Web of Science ®Google Scholar
• Li SY, Li PW, Shen B, Zhi M, Gu YB, Wang XY, Guo H, Li Y, Fan YH, Yang BL, et al. Insufficient awareness and vaccination practices for inflammatory bowel disease patients in China: a multi-center survey of Chinese gastroenterologists. J Dig Dis. 2020 Jan;21(1):46–51. doi:10.1111/1751-2980.12834.
   PubMed Web of Science ®Google Scholar
• Page MJ, JE M, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021 March 29;372:n71. doi:10.1136/bmj.n71.
   PubMedGoogle Scholar
• Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa, ON, Canada: Ottawa Health Research Institute; 2014.
   Google Scholar
• Mikhael E, Khalife Y, Yaghi C, Khoury B, Khazaka S, Khoueiry C, Safar K, Sayegh RB, Honein K, Slim R. Perception and attitude of Lebanese IBD patients during the COVID-19 pandemic. Patient Prefer Adherence. 2023 Aug 15;17:1967–75. doi:10.2147/PPA.S423520.
   PubMed Web of Science ®Google Scholar
• Principi M, Macaluso FS, Todeschini A, Facciotti F, Contaldo A, Castiglione F, Nardone OM, Spagnuolo R, Doldo P, Riguccio G, et al. Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: data of a national study (ESCAPE-IBD). Eur J Gastroenterol Hepatol. 2023 Jun 1;35(6):629–34. doi:10.1097/MEG.0000000000002550.
   PubMed Web of Science ®Google Scholar
• Ramos L, Carrillo-Palau M, Alonso-Abreu I, Reygosa C, Hernández-Alvarez N, Amaral C, Hernández A, Benítez-Zafra F, Pérez-González F, Quintana-Díaz H, et al. COVID-19 vaccination rate and willingness of an additional dose among inflammatory bowel disease patients receiving biologic therapy: fearless and with desire. Gastroenterol Hepatol. 2023 Apr;46(4):255–60. doi:10.1016/j.gastrohep.2022.05.009.
   PubMed Web of Science ®Google Scholar
• Cao Y, Feng J, Duan S, Yang Y, Zhang Y. SARS-CoV-2-inactivated vaccine hesitancy and the safety in inflammatory bowel disease patients: a single-center study. Therap Adv Gastroenterol. 2022 Jun 11;15:17562848221101722. doi:10.1177/17562848221101722.
   Web of Science ®Google Scholar
• Caron B, Neuville E, Peyrin-Biroulet L. Inflammatory bowel disease and COVID-19 vaccination: a patients’ survey. Dig Dis Sci. 2022 Jun;67(6):2067–73. doi:10.1007/s10620-021-07040-z.
   PubMed Web of Science ®Google Scholar
• Clarke K, Pelton M, Stuart A, Tinsley A, Dalessio S, Bernasko N, Williams ED, Coates M. COVID-19 vaccine hesitancy in patients with inflammatory bowel disease. Dig Dis Sci. 2022 Oct;67(10):4671–7. doi:10.1007/s10620-021-07377-5.
   PubMed Web of Science ®Google Scholar
• Costantino A, Noviello D, Conforti FS, Aloi M, Armuzzi A, Bossa F, Ficari F, Leone S, Manguso F, Mocci G, et al. COVID-19 vaccination willingness and hesitancy in patients with inflammatory bowel diseases: analysis of determinants in a national survey of the Italian IBD patients’ association. Inflamm Bowel Dis. 2022 Mar 2;28(3):474–8. doi:10.1093/ibd/izab172.
   PubMed Web of Science ®Google Scholar
• Duong TA, Bryant RV, Andrews JM, Lynch KD. Attitudes towards COVID-19 vaccination in patients with inflammatory bowel disease. Intern Med J. 2022 Jun;52(6):1070–4. doi:10.1111/imj.15722.
   PubMed Web of Science ®Google Scholar
• Ferreiro-Iglesias R, Hernández-Camba A, Serrano Labajos R, Rodríguez-Lago I, Zabana Y, Acosta M B-D, Young Group of Geteccu, ACCU Spain. SARS-CoV-2 vaccine acceptance among gastroenterologists and inflammatory bowel disease patients: VACUNEII project. Gastroenterol Hepatol. 2022 Dec;45(10):737–41. doi:10.1016/j.gastrohep.2021.08.004.
   PubMed Web of Science ®Google Scholar
• Herman HS, Rosenthaler MP, Elhassan N, Weinberg JM, Satyam VR, Wasan SK. COVID-19 vaccine hesitancy among patients with inflammatory bowel diseases at a diverse safety net hospital. Dig Dis Sci. 2022 Nov;67(11):5029–33. doi:10.1007/s10620-022-07413-y.
   PubMed Web of Science ®Google Scholar
• Hu S, Liu J, Li S, Wu Q, Wang X, Xu D, Chen Y. Patients with IBD have a more cautious attitude towards COVID-19 vaccination. Front Immunol. 2023 Jan 18;13:1077308. doi:10.3389/fimmu.2022.1077308.
   PubMed Web of Science ®Google Scholar
• Hudhud D, Caldera F, Cross RK. Addressing COVID-19 vaccine hesitancy in patients with IBD. Inflamm Bowel Dis. 2022 Mar 2;28(3):492–3. doi:10.1093/ibd/izab241.
   PubMed Web of Science ®Google Scholar
• Łodyga M, Maciejewska K, Rydzewska G. A prospective questionnaire-based study to evaluate factors affecting the decision to receive COVID-19 vaccination in 267 patients with inflammatory bowel disease in Poland. Med Sci Monit. 2023 Dec 7;28:e938665. doi:10.12659/MSM.938665.
   PubMed Web of Science ®Google Scholar
• Orfanoudaki E, Zacharopoulou E, Kitsou V, Karmiris K, Theodoropoulou A, Mantzaris GJ, Tzouvala M, Michopoulos S, Zampeli E, Michalopoulos G, et al. Real-World use and adverse events of SARS-CoV-2 vaccination in Greek patients with inflammatory bowel disease. J Clin Med. 2023 Jan 27;11(3):641. doi:10.3390/jcm11030641.
   PubMed Web of Science ®Google Scholar
• Shehab M, Alrashed F, Alfadhli A. COVID-19 vaccine booster dose willingness among patients with inflammatory bowel disease on Infliximab and Vedolizumab: a cross-sectional study. Vaccines. 2022 Jul 22;10(8):1166. doi:10.3390/vaccines10081166.
   Web of Science ®Google Scholar
• Zhang E, Gupta A, Al-Ani A, Macrae FA, Leong RW, Christensen B. Misconceptions drive COVID-19 vaccine hesitancy in individuals with inflammatory bowel disease. Can J Gastroenterol Hepatol. 2022 Sep 10;2022:4527844. doi:10.1155/2022/4527844.
   PubMed Web of Science ®Google Scholar
• Crispino F, Brinch D, Carrozza L, Cappello M. Acceptance of SARS-CoV-2 vaccination among a cohort of IBD patients from Southern Italy: a cross-sectional survey. Inflamm Bowel Dis. 2021 Oct 20;27(11):134–5. doi:10.1093/ibd/izab133.
   PubMed Web of Science ®Google Scholar
• Dalal RS, McClure E, Marcus J, Winter RW, Hamilton MJ, Allegretti JR. COVID-19 vaccination intent and perceptions among patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2021 Aug;19(8):1730–2.e2. doi:10.1016/j.cgh.2021.02.004.
   PubMed Web of Science ®Google Scholar
• Napolitano D, Privitera G, Schiavoni E, Turchini L, Amatucci V, Pugliese D, Gasbarrini A, Scaldaferri F, Armuzzi A. The educational role of IBD nurses in Italy in vaccinations: do not miss the moment for COVID-19. Eur Rev Med Pharmacol Sci. 2021 Sep;25(17):5542–6. doi:10.26355/eurrev_202109_26666.
   PubMed Web of Science ®Google Scholar
• Nishida Y, Hosomi S, Kobayashi Y, Nakata R, Ominami M, Nadatani Y, Fukunaga S, Otani K, Tanaka F, Nagami Y, et al. Acceptance of COVID-19 vaccines among patients with inflammatory bowel disease in Japan. Healthcare (Basel). 2021 Dec 22;10(1):6. doi:10.3390/healthcare10010006.
   PubMedGoogle Scholar
• Viola A, Muscianisi M, Voti RL, Costantino G, Alibrandi A, Fries W. Predictors of covid-19 vaccination acceptance in IBD patients: a prospective study. Eur J Gastroenterol Hepatol. 2021 Dec 1 1045;33(1S Suppl 1):e1042–e. doi:10.1097/MEG.0000000000002320.
   PubMedGoogle Scholar
• Walldorf J, von Arnim U, Schmelz R, Riesner-Wehner A, Michl P, Grunert PC, Stallmach A, Teich N, Reuken PA. SARS-CoV-2 vaccination in patients with inflammatory bowel disease-fear and desire. Inflamm Bowel Dis. 2021 Oct 20;27(11):1858–61. doi:10.1093/ibd/izab150.
   PubMed Web of Science ®Google Scholar
• Wu X, Lin J, Buch H, Ding Q, Zhang F, Cui B, Ji G. The COVID-19 vaccination hesitancy among the people with inflammatory bowel disease in China: a questionnaire study. Front Public Health. 2021 Oct 11;9:731578. doi:10.3389/fpubh.2021.731578.
   PubMed Web of Science ®Google Scholar
• Bhat S, Caldera F, Farraye FA. Barriers to administering vaccines in inflammatory bowel disease centers. Inflamm Bowel Dis. 2021 Jul 27;27(8):1356–7. doi:10.1093/ibd/izab055.
   PubMed Web of Science ®Google Scholar
• Papa A, Gasbarrini A, Lopetuso LR. Winter is coming and COVID-19 vaccine is available! the role of gastroenterologist in increasing covid-19 vaccine acceptability among ibd patients. Gastroenterology. 2021 Jul;161(1):368–9. doi:10.1053/j.gastro.2020.12.066.
   PubMed Web of Science ®Google Scholar
• Papa A, Scaldaferri F, Vetrone LM, Neri M, Gasbarrini A, Lopetuso LR. How to face the advent of SARS-CoV-2 vaccination in IBD patients: another task for gastroenterologists. Vaccines. 2021 Mar 12;9(3):248. doi:10.3390/vaccines9030248.
   Web of Science ®Google Scholar
• Bianchi FP, Stefanizzi P, Martinelli A, Brescia N, Tafuri S. COVID-19 vaccination hesitancy in people affected by diabetes and strategies to increase vaccine compliance: a systematic narrative review and meta-analysis. Vaccine. 2023 Feb 10;41(7):1303–9. doi:10.1016/j.vaccine.2023.01.036.
   PubMed Web of Science ®Google Scholar
• Bianchi FP, Stefanizzi P, Di Gioia MC, Brescia N, Lattanzio S, Tafuri S. COVID-19 vaccination hesitancy in pregnant and breastfeeding women and strategies to increase vaccination compliance: a systematic review and meta-analysis. Expert Rev Vaccines. 2022 Oct;21(10):1443–54. doi:10.1080/14760584.2022.2100766.
   PubMed Web of Science ®Google Scholar
• Ejamo JY, Legese GL, Tesfaye YA, Liben FE. COVID-19 vaccine acceptance among people living with HIV: a systematic review and meta-analysis. Trop Med Int Health. 2023 Aug;28(8):601–11. doi:10.1111/tmi.13908.
   PubMed Web of Science ®Google Scholar
• Bianchi FP, Stefanizzi P, Brescia N, Lattanzio S, Martinelli A, Tafuri S. COVID-19 vaccination hesitancy in Italian healthcare workers: a systematic review and meta-analysis. Expert Rev Vaccines. 2022 Sep;21(9):1289–300. doi:10.1080/14760584.2022.2093723.
   PubMed Web of Science ®Google Scholar
• Ali HA, Hartner AM, Echeverria-Londono S, Roth J, Li X, Abbas K, Portnoy A, Vynnycky E, Woodruff K, Ferguson NM, et al. Vaccine equity in low and middle income countries: a systematic review and meta-analysis. Int J Equity Health. 2022 Jun 11;21(1):82. doi:10.1186/s12939-022-01678-5.
   PubMed Web of Science ®Google Scholar
• Lawal L, Aminu Bello M, Murwira T, Avoka C, Yusuf Ma’aruf S, Harrison Omonhinmin I, Maluleke P, Tsagkaris C, Onyeaka H. Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward. Hum Vaccin Immunother. 2022 Dec 31;18(1):2034457. doi:10.1080/21645515.2022.2034457.
   PubMed Web of Science ®Google Scholar
• Chan W, Salazar E, Lim TG, Ong WC, Shim HH. Vaccinations and inflammatory bowel disease - a systematic review. Dig Liver Dis. 2021 Sep;53(9):1079–88. doi:10.1016/j.dld.2021.04.015.
   PubMedGoogle Scholar
• Sitte J, Frentiu E, Baumann C, Rousseau H, May T, Bronowicki JP, Peyrin-Biroulet L, Lopez A. Vaccination for influenza and pneumococcus in patients with gastrointestinal cancer or inflammatory bowel disease: a prospective cohort study of methods for improving coverage. Aliment Pharmacol Ther. 2019 Jan;49(1):84–90. doi:10.1111/apt.15057.
   PubMed Web of Science ®Google Scholar
• Narula N, Dhillon AS, Chauhan U, Marshall JK. An audit of influenza vaccination status in adults with inflammatory bowel disease. Can J Gastroenterol. 2012 Sep;26(9):593–6. doi:10.1155/2012/158362.
   PubMed Web of Science ®Google Scholar
• Núñez P, Quera R, Flores L, Araya R, Córdova A, Correa I. Role of the multidisciplinary team in pandemics: a new opportunity to achieve greater immunization in patients with inflammatory bowel disease. Dig Liver Dis. 2022 Apr;54(4):562–4. doi:10.1016/j.dld.2021.12.013.
   PubMedGoogle Scholar
• Manser CN, Maillard MH, Rogler G, Schreiner P, Rieder F, Bühler S. On behalf of Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology. Vaccination in patients with inflammatory bowel diseases. Digestion. 2020;101 Suppl 1(Suppl 1):58–68. doi:10.1159/000503253.
   PubMed Web of Science ®Google Scholar
• D’Amato S, Pellicanò GF, Nunnari G, Fedele F, Squeri R, Mazzitelli F, D’Andrea F, Maisano D, Squeri R, Genovese C. Management care improvement of people living with HIV: definition of a targeted clinical pathway in a University Hospital of South Italy. Acta Biomed. 2021 Sep 2;92(4):e2021244.
   PubMedGoogle Scholar
• Bianchi FP, Rizzo LA, De Nitto S, Stefanizzi P, Tafuri S. Influenza vaccination coverage among splenectomized patients: an Italian study on the role of active recall in the vaccination compliance. Hum Vaccin Immunother. 2019;15(11):2644–9. doi:10.1080/21645515.2019.1599678.
   PubMed Web of Science ®Google Scholar